Natural language processing for patient selection in phase I/II oncology clinical trials
Julie Delorme, Valentin Charvet, Muriel Wartelle, François Lion, Bruno Thuillier, Sandrine Mercier, Jean-Charles Soria, Mikael Azoulay, Benjamin Besse, Christophe Massard, Antoine Hollebecque, View ORCID ProfileLoic Verlingue
doi: https://doi.org/10.1101/2021.02.07.21249271
Julie Delorme
1Institut Optique Graduate School, Paris, France
Valentin Charvet
2Telecom Paris Tech, Paris, France
3Department of Computing Science, University of Glasgow, Glasgow G12 8RZ
Muriel Wartelle
4Informatic Team (DTNSI), Gustave Roussy, Villejuif, France
François Lion
4Informatic Team (DTNSI), Gustave Roussy, Villejuif, France
Bruno Thuillier
5Drug Development Department (DITEP), Gustave Roussy, Villejuif, France
Sandrine Mercier
5Drug Development Department (DITEP), Gustave Roussy, Villejuif, France
Jean-Charles Soria
5Drug Development Department (DITEP), Gustave Roussy, Villejuif, France
6University Paris-Saclay, France
7Medical Oncology Department, Gustave Roussy, Villejuif, France
Mikael Azoulay
4Informatic Team (DTNSI), Gustave Roussy, Villejuif, France
Benjamin Besse
6University Paris-Saclay, France
7Medical Oncology Department, Gustave Roussy, Villejuif, France
Christophe Massard
5Drug Development Department (DITEP), Gustave Roussy, Villejuif, France
6University Paris-Saclay, France
Antoine Hollebecque
5Drug Development Department (DITEP), Gustave Roussy, Villejuif, France
Loic Verlingue
5Drug Development Department (DITEP), Gustave Roussy, Villejuif, France
6University Paris-Saclay, France
8INSERM UMR1030, Molecular Radiotherapy and Therapeutic Innovations, Gustave Roussy, Villejuif, France
Article usage
Posted February 08, 2021.
Natural language processing for patient selection in phase I/II oncology clinical trials
Julie Delorme, Valentin Charvet, Muriel Wartelle, François Lion, Bruno Thuillier, Sandrine Mercier, Jean-Charles Soria, Mikael Azoulay, Benjamin Besse, Christophe Massard, Antoine Hollebecque, Loic Verlingue
medRxiv 2021.02.07.21249271; doi: https://doi.org/10.1101/2021.02.07.21249271
Natural language processing for patient selection in phase I/II oncology clinical trials
Julie Delorme, Valentin Charvet, Muriel Wartelle, François Lion, Bruno Thuillier, Sandrine Mercier, Jean-Charles Soria, Mikael Azoulay, Benjamin Besse, Christophe Massard, Antoine Hollebecque, Loic Verlingue
medRxiv 2021.02.07.21249271; doi: https://doi.org/10.1101/2021.02.07.21249271
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (628)
- Anesthesia (165)
- Cardiovascular Medicine (2378)
- Dermatology (207)
- Emergency Medicine (379)
- Epidemiology (11775)
- Forensic Medicine (10)
- Gastroenterology (703)
- Genetic and Genomic Medicine (3746)
- Geriatric Medicine (350)
- Health Economics (634)
- Health Informatics (2399)
- Health Policy (933)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (365)
- Medical Ethics (105)
- Nephrology (398)
- Neurology (3508)
- Nursing (198)
- Nutrition (526)
- Oncology (1824)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (233)
- Palliative Medicine (66)
- Pathology (446)
- Pediatrics (1035)
- Primary Care Research (420)
- Public and Global Health (6145)
- Radiology and Imaging (1280)
- Respiratory Medicine (828)
- Rheumatology (379)
- Sports Medicine (323)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (146)